Finance

Lists
003220:KRX
Daewon Pharmaceutical Co Ltd
8 000,00 KRW
+1,52%
(+120,00) 1D
19 ოქტ, 15:30:28 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 003220...
Open
7 720 KRW
High
8 000 KRW
Low
7 720 KRW
Mkt. cap
179,42 მლრ.
Avg. vol.
49,23 ათ.
Volume
20,17 ათ.
Dividend
3,12%
Quarterly dividend
62 KRW
Ex-dividend date
29 დეკ. 2025
P/E ratio
68,28
52-wk high
13 670 KRW
52-wk low
7 060 KRW
EPS
117 KRW
Shares outstanding
22,43 მლნ.
No. of employees
1 ათ.
Open
7 720 KRW
High
8 000 KRW
Low
7 720 KRW
Mkt. cap
179,42 მლრ.
Avg. vol.
49,23 ათ.
Volume
20,17 ათ.
Dividend
3,12%
Quarterly dividend
62 KRW
Ex-dividend date
29 დეკ. 2025
P/E ratio
68,28
52-wk high
13 670 KRW
52-wk low
7 060 KRW
EPS
117 KRW
Shares outstanding
22,43 მლნ.
No. of employees
1 ათ.
News stories
From web sources and news partners
About Daewon Pharmaceutical Co Ltd
CEOBaek Seung-yeol | ჯონათან ინ ბაეკ
Employees1,24 ათ.
Founded1958
Headquarters-
SectorPharmaceutical industry
Websitedaewonpharm.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
143,94 მლრ.
159,81 მლრ.
158,06 მლრ.
152,83 მლრ.
Cost of goods sold
83,20 მლრდ.
86,55 მლრდ.
83,32 მლრდ.
82,01 მლრდ.
Cost of revenue
83,20 მლრდ.
86,55 მლრდ.
83,32 მლრდ.
82,01 მლრდ.
Research and development expenses
6,44 მლრდ.
6,55 მლრდ.
6,78 მლრდ.
4,84 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
61,82 მლრდ.
58,27 მლრდ.
60,97 მლრდ.
63,81 მლრდ.
Operating expense
71,13 მლრდ.
67,39 მლრდ.
70,35 მლრდ.
70,77 მლრდ.
Total operating expenses
154,33 მლრ.
153,93 მლრ.
153,67 მლრ.
152,79 მლრ.
Operating income
-10,39 მლრდ.
5,88 მლრდ.
4,38 მლრდ.
43,44 მლნ.
Other non operating income
-1,24 მლრდ.
-2,49 მლრდ.
127,02 მლნ.
2,35 მლრდ.
EBT including unusual items
-12,01 მლრდ.
11,79 მლრდ.
3,92 მლრდ.
5,35 მლრდ.
EBT excluding unusual items
-11,95 მლრდ.
2,77 მლრდ.
4,15 მლრდ.
3,31 მლრდ.
Income tax expense
6,02 მლრდ.
-2,45 მლრდ.
1,83 მლრდ.
1,35 მლრდ.
Effective tax rate
-50,14%
-20,77%
46,72%
25,25%
Other operating expenses
890,07 მლნ.
847,43 მლნ.
869,07 მლნ.
818,26 მლნ.
Net income
-17,41 მლრდ.
13,60 მლრდ.
2,42 მლრდ.
4,03 მლრდ.
Net profit margin
-12,10%
8,51%
1,53%
2,64%
Earnings per share
-
-
-
-
Interest and investment income
150,63 მლნ.
346,40 მლნ.
449,07 მლნ.
307,63 მლნ.
Interest expense
-1,98 მლრდ.
-1,40 მლრდ.
-1,74 მლრდ.
-1,65 მლრდ.
Net interest expenses
-1,82 მლრდ.
-1,06 მლრდ.
-1,29 მლრდ.
-1,34 მლრდ.
Depreciation and amortization charges
1,15 მლრდ.
1,06 მლრდ.
1,05 მლრდ.
1,08 მლრდ.
EBITDA
-4,51 მლრდ.
11,94 მლრდ.
10,76 მლრდ.
6,31 მლრდ.
Gain or loss from assets sale
-197,23 მლნ.
1,85 მლრდ.
4,90 მლნ.
-1,76 მლრდ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები